We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

128 hedge funds and large institutions have $369M invested in Keryx Biopharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $313M → $369M (+$56.5M)

7% less funds holding

Funds holding: 138 → 128 (-10)

12% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 42

31% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 32

38% less call options, than puts

Call options by funds: $4.4M | Put options by funds: $7.14M

Holders
128
Holders Change
-10
Holders Change %
-7.25%
% of All Funds
3.36%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
37
Reduced
42
Closed
32
Calls
$4.4M
Puts
$7.14M
Net Calls
-$2.74M
Net Calls Change
-$733K

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$7.25M
2
Millennium Management
Millennium Management
New York
+$4.28M
3
Norges Bank
Norges Bank
Norway
+$4.13M
4
ACM
Abrams Capital Management
Massachusetts
+$2.38M
5
BGIM
Brandywine Global Investment Management
Pennsylvania
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$20.1M
2
State Street
State Street
Massachusetts
-$13.6M
3
ORI
Oak Ridge Investments
Illinois
-$11.1M
4
ACM
Apex Capital Management
Ohio
-$5.97M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.74M +$2.73K +575 +0.2%
RA
27
Royce & Associates
New York
$1.73M +$1.62M +341,725 New
TCIM
28
TIAA CREF Investment Management
New York
$1.7M -$54.1K -11,384 -3%
MSU
29
Mizuho Securities USA
New York
$1.55M +$257K +54,100 +21%
CCM
30
Century Capital Management
Massachusetts
$1.38M +$1.3M +272,773 New
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$1.21M – – –
1832 Asset Management
32
1832 Asset Management
Ontario, Canada
$1.16M – – –
KCM
33
Knoll Capital Management
Florida
$1.01M – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$970K +$16.1K +3,380 +2%
AllianceBernstein
35
AllianceBernstein
Tennessee
$892K – – –
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$872K -$818K -172,157 -50%
TA
37
Teachers Advisors
New York
$862K +$83.5K +17,568 +11%
Morgan Stanley
38
Morgan Stanley
New York
$854K +$80.7K +16,976 +11%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$794K +$184K +38,664 +33%
Swiss National Bank
40
Swiss National Bank
Switzerland
$728K – – –
RT
41
Rockland Trust
Massachusetts
$723K – – –
VEA
42
Virtus ETF Advisers
New York
$689K +$648K +136,472 New
Group One Trading
43
Group One Trading
Illinois
$633K +$358K +75,439 +151%
CS
44
Credit Suisse
Switzerland
$594K +$304K +63,957 +119%
WMSA
45
Weiss Multi-Strategy Advisers
New York
$561K – – –
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$542K +$36.9K +7,770 +8%
AIG
47
American International Group
New York
$489K -$20.2K -4,248 -4%
UBS AM
48
UBS AM
Illinois
$435K -$5.71M -1,202,181 -93%
FWM
49
Frontier Wealth Management
Missouri
$426K -$61.8K -13,000 -13%
Squarepoint
50
Squarepoint
New York
$405K +$381K +80,151 New
1
2
3 4 5

KERX Hedge Fund Activity: Q4 2015 in Review

128 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q4 2015, worth a combined $369M — up 18% from $313M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of KERX and 22 opened new positions — a net loss of 10 holders — while 42 trimmed existing stakes and 37 added.

The largest buyer was Ameriprise, adding an estimated $7.25M. The largest seller was Franklin Resources, cutting an estimated $20.1M.

  • 128 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q4 2015, down from 138 in Q3 2015.
  • Funds reported $369M of Keryx Biopharmaceuticals Inc stock for Q4 2015, up 18% quarter-over-quarter.
  • 22 funds opened new Keryx Biopharmaceuticals Inc positions in Q4 2015 and 32 closed out, a net change of -10 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q4 2015 was Ameriprise, an estimated $7.25M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q4 2015 was Franklin Resources, an estimated $20.1M sold.

Based on aggregated 13F filings for Q4 2015.